Novartis Korea sales rise, profits drop

Published: 2012-04-10 06:56:00

Updated: 2012-04-10 06:56:00

Novartis Korea, a Korean unit of Novartis Group, said yesterday it posted 478.7 billion won in revenue last year, up 9.86 percent a year earlier, but the company’s operating profit dipped more than 24 percent year-on-year to 27.9 billion won.

Its net profit of 19.3 billion won was more than a ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK